ANGPTL3 gene variants in subjects with familial combined hyperlipidemia
Abstract Angiopoietin-like 3 (ANGPTL3) plays an important role in lipid metabolism in humans. Loss-of-function variants in ANGPTL3 cause a monogenic disease named familial combined hypolipidemia. However, the potential contribution of ANGPTL3 gene in subjects with familial combined hyperlipidemia (F...
Main Authors: | A. M. Bea, E. Franco-Marín, V. Marco-Benedí, E. Jarauta, I. Gracia-Rubio, A. Cenarro, F. Civeira, I. Lamiquiz-Moneo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-86384-y |
Similar Items
-
Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
by: Estíbaliz Jarauta, et al.
Published: (2020-12-01) -
Association between non-cholesterol sterol concentrations and Achilles tendon thickness in patients with genetic familial hypercholesterolemia
by: Lucía Baila-Rueda, et al.
Published: (2018-01-01) -
ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
by: Cui, W., et al.
Published: (2022) -
FABP4 plasma levels are increased in familial combined hyperlipidemia
by: Anna Cabré, et al.
Published: (2010-05-01) -
Serum and urine ANGPTL8 expression levels are associated with hyperlipidemia and proteinuria in primary nephrotic syndrome
by: Yue Li, et al.
Published: (2021-04-01)